RESUMEN
We have previously described a SWI/SNF-related protein complex (PYR complex) that is restricted to definitive (adult-type) hematopoietic cells and that specifically binds DNA sequences containing long stretches of pyrimidines. Deletion of an intergenic DNA-binding site for this complex from a human beta-globin locus construct results in delayed human gamma- to beta-globin switching in transgenic mice, suggesting that the PYR complex acts to facilitate the switch. We now show that PYR complex DNA-binding activity also copurifies with subunits of a second type of chromatin-remodeling complex, nucleosome-remodeling deacetylase (NuRD), that has been shown to have both nucleosome-remodeling and histone deacetylase activities. Gel supershift assays using antibodies to the ATPase-helicase subunit of the NuRD complex, Mi-2 (CHD4), confirm that Mi-2 is a component of the PYR complex. In addition, we show that the hematopoietic cell-restricted zinc finger protein Ikaros copurifies with PYR complex DNA-binding activity and that antibodies to Ikaros also supershift the complex. We also show that NuRD and SWI/SNF components coimmunopurify with each other as well as with Ikaros. Competition gel shift experiments using partially purified PYR complex and recombinant Ikaros protein indicate that Ikaros functions as a DNA-binding subunit of the PYR complex. Our results suggest that Ikaros targets two types of chromatin-remodeling factors-activators (SWI/SNF) and repressors (NuRD)-in a single complex (PYR complex) to the beta-globin locus in adult erythroid cells. At the time of the switch from fetal to adult globin production, the PYR complex is assembled and may function to repress gamma-globin gene expression and facilitate gamma- to beta-globin switching.
Asunto(s)
Autoantígenos , Cromatina/química , Cromatina/metabolismo , Proteínas de Unión al ADN/metabolismo , Leucemia Eritroblástica Aguda/metabolismo , Factores de Transcripción/metabolismo , Adenosina Trifosfatasas/metabolismo , Envejecimiento/fisiología , Animales , Cromatina/genética , ADN/genética , ADN/metabolismo , ADN Helicasas/metabolismo , Regulación de la Expresión Génica , Globinas/genética , Histona Desacetilasas/metabolismo , Histonas/química , Histonas/metabolismo , Humanos , Factor de Transcripción Ikaros , Leucemia Eritroblástica Aguda/patología , Sustancias Macromoleculares , Complejo Desacetilasa y Remodelación del Nucleosoma Mi-2 , Ratones , Ratones Transgénicos , Proteínas Nucleares/metabolismo , Pruebas de Precipitina , Unión Proteica , Complejo Correpresor Histona Desacetilasa y Sin3 , Especificidad por Sustrato , Células Tumorales Cultivadas , Dedos de ZincRESUMEN
Hematopoietic stem cells (HSCs) are multipotent self-renewing precursors with the capacity to differentiate into all adult blood cell lineages. HSC development is a highly orchestrated process regulated by multiple transcription factors and signaling pathways. Emerging evidence suggests that epigenetic regulation is an additional essential component of HSC development. Powerful genetic and imaging approaches, combined with conservation of mammalian programs, have made zebrafish a prominent model for the study of HSC production. This chapter summarizes approaches that have been used to identify epigenetic regulators of HSC development in zebrafish and highlights additional strategies that are likely to facilitate progress in this promising field.